In silico analysis of indole-3-carbinol and its metabolite DIM as EGFR tyrosine kinase inhibitors in platinum resistant ovarian cancer
Dash R, Hosen SMZ, Karim MR, Kabir MSH, Hossain MM, Junaid MA, Islam MA, Paul A, Khan MA
Share & cite
Links open in a new tab.
Citation record
- Year
- 2015
- Journal
- Journal of Applied Pharmaceutical Science
- WikiBiome key
dash-2015-indole-3-carbinol-dim-egfr-ovarian-cancer
Used in 3 visible records
metalPlatinum→diseaseOvarian Cancer→interventionIndole-3-Carbinol (I3C) for Ovarian Cancer→Researcher discussion
0 postsConnect the evidence
Publicly readable discussion by ORCID-authenticated researchers. Questions, interpretation, methods, corrections, and new evidence stay attached to this record.
No discussion yet. Start with a precise question or a source-backed observation.
Transparent record
0 changesPublished page changes
This record shows only material changes published on this page, including changes to its content, evidence, conclusions, or author context. Internal processes and discussion activity are excluded. Pending, declined, and withdrawn proposals remain private.
No material page changes have been recorded yet.
